OMER, Israel, April 2, 2015 (GLOBE NEWSWIRE) -- Medigus Ltd. (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, announced today that data on the Medigus Ultrasonic Surgical Endostapler (MUSE), an incisionless procedure for the treatment of gastroesophageal reflux disease (GERD), will be presented in a poster presentation at the upcoming Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Annual Meeting, taking place April 15 - 17, 2015 at the Gaylord Opryland Hotel and Convention Center, Nashville, Tennessee.
In addition, Santiago Horgan, MD, FACS and Chief, Division of Minimally Invasive Surgery at University of California at San Diego, will be presenting on MUSE (formerly called SRS) technology during a panel presentation taking place on Wednesday April 15th, from 1:30 - 3:30 PM.
The MUSE system is an intuitive device that integrates recent breakthroughs in visualization, ultrasound and surgical stapling capabilities, into a single platform, making it easy for a single physician to perform fundoplication (stapling of the upper part of the stomach, or fundus, to the lower esophageal sphincter) for the treatment of GERD. MUSE is leading the transition to more patient-friendly procedures for the long-term treatment of this prevalent disorder.
"We are looking forward to the presentation on the latest data on MUSE during the SAGES meeting," said Chris Rowland, CEO of Medigus. "This provides another important opportunity to connect and share information with additional clinicians who may be interested in using the MUSE system and also want to discuss how to get the best results with these GERD patients by using a less invasive option."
Panel: Technology Innovation from Overseas (Program of the Americas)
Panel Session, Delta Ballroom C
Wednesday April 15, 2015 from 1:30 - 1:45 PM
-
Endoscopic Anterior Fundoplication with the Medigus SRS Transoral Surgical Stapler
Being presented by Santiago Horgan, MD, FACS
The MUSE Poster Presentation at SAGES
Poster Presentations, Ryman Exhibit Hall C
Thursday and Friday, April 16-17, 2015 from 9:30 AM - 4:00 PM
-
Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE): results from an ex vivo simulation trial to assess the efficacy of the procedure by comparing stapling position and gastric yield pressures
Being presented by Tae-Geun Gweon, MD, Beth Israel Deaconess Medical Center
For more information about MUSE, please visit the Medigus booth in the Ryman Exhibit Hall C, Booth # 644.
About SAGES
The mission of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) is to improve quality patient care through education, research, innovation and leadership, principally in gastrointestinal and endoscopic surgery. The SAGES 2015 Annual Meeting will be held at the Gaylord Opryland Hotel and Convention Center in Nashville, TN, April 15 though 17. For more information about the annual meeting visit www.sages2015.org or www.sages.org.
About MUSE
The MUSE system is a leading technology in Natural Orifice Endoscopic Surgery procedures. The single operator system performs anterior partial fundoplication with standard surgical staples in a less invasive way, compared to other surgical procedures. Its intuitive endosurgical platform consists of a single use flexible surgical endostapler, equipped with a proprietary miniature camera, an ultrasonic sight and a range finder. The endostapler, which resembles an endoscope, is designed to be operated by a single user, includes a handle with controls, an 80cm flexible shaft, a 5cm rigid section holding a cartridge with 5 standard 4.8mm titanium surgical staples, a ratchet controlled one-way articulating section, and a distal tip. The MUSE system is FDA cleared and CE marked. Medigus anticipates that the new Category 1 Current Procedural Terminology (CPT®) code, recently created by The American Medical Association (AMA) for Esophagogastric Fundoplasty Trans-Orifice Approach procedures, would be the code used for MUSE.
About Medigus
Medigus is a medical device company specializing in developing minimally invasive endosurgical tools and highly innovative imaging solutions. Medigus is a pioneer developer of a unique proprietary endoscopic device, the MUSE(TM) system, to treat gastroesophageal reflux disease (GERD), one of the most common chronic diseases in the western world. As an expert in micro-endoscopic devices, Medigus has developed a range of micro CMOS (complementary metal-oxide semiconductor) and CCD (charge-coupled device) video cameras, including micro ScoutCam(TM) 1.2, which to the best of the company's knowledge, is the smallest in the world. These innovative cameras are suitable for both medical and industrial applications. The MUSE system incorporates Medigus' revolutionary micro ScoutCam technology. Based on its proprietary technologies, Medigus designs and manufactures endoscopy and micro camera systems for partner companies, including major players in the medical and industrial fields. The company is committed to providing integrated solutions to meet all of its customer's imaging needs. Medigus is traded on the TASE (Tel-Aviv Stock Exchange). To learn more about the company's advanced technology, please visit www.medigus.com or www.microscoutcam.com.
###
MEDIA CONTACT:
Chantal Beaudry/ Carrie Yamond
Lazar Partners Ltd.
212-867-1762
cbeaudry@lazarpartners.com
cyamond@lazarpartners.com
INVESTOR RELATIONS:
Miri Segal-Scharia
Hayden/ MS-IR LLC
917-607-8654
msegal@ms-ir.com
HUG#1908470